Digistain Analysis
What is Digistain?
Digistain offers an AI-enabled tumor profiling test to evaluate breast cancer recurrence risk, facilitating personalized treatment decisions for patients post-surgery.
Employees
40
Founded
2019
Revenue
$2.3M
Company Stage
Seed
Investors
- Sofia Angels Ventures
YC Batch
S21
Product Features & Capabilities
- tumour profiling technology, Digistain Prognostic Score, predicts 10-year risk of recurrence, personalized treatment plans, results in under 1 hour, lower costs, seamless integration with clinical workflows
Who are the founders of Digistain
HA
CP
Chris Phillips
Founder
See something that needs updating? Suggest edits to this profile.